Masayuki Isaji

Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level

Kenji Katsuno, Yoshikazu Fujimori, Yukiko Takemura et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 265 citations

Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models

Yoshikazu Fujimori, Kenji Katsuno, Ikumi Nakashima et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 219 citations

SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose

Shigeki Tazawa, Tokuhisa Yamato, Hideki Fujikura et al. · Life Sciences · 2004 · 202 citations

Essential Transporter, Biochemistry, Natural Sciences +6

Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells <i>in vitro</i> and angiogenesis <i>in vivo</i>

Masayuki Isaji, Hiroshi Miyata, Yoshiyuki Ajisawa et al. · British Journal of Pharmacology · 1997 · 100 citations · Full text

Sodium-glucose cotransporter inhibitors for diabetes.

Masayuki Isaji · PubMed · 2007 · 86 citations

Renal Glucose Excretion, Sodium-glucose Cotransporter Inhibitors, Pharmacotherapy +19